RU2711629C1 - Method for treating influenza and quinsy strains and composition for its implementation - Google Patents
Method for treating influenza and quinsy strains and composition for its implementation Download PDFInfo
- Publication number
- RU2711629C1 RU2711629C1 RU2018139177A RU2018139177A RU2711629C1 RU 2711629 C1 RU2711629 C1 RU 2711629C1 RU 2018139177 A RU2018139177 A RU 2018139177A RU 2018139177 A RU2018139177 A RU 2018139177A RU 2711629 C1 RU2711629 C1 RU 2711629C1
- Authority
- RU
- Russia
- Prior art keywords
- iridium
- immune system
- influenza
- metabolic processes
- angina
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Изобретение относится к здравоохранению и может быть использовано при лечении штаммов гриппа и ангины.The invention relates to healthcare and can be used in the treatment of strains of influenza and tonsillitis.
Известен способ стимуляции иммунной системы человека, включающий введение терапевтических доз соединений минерала осмистый иридий раздельно с мумие и прополисом в соотношениях 1:1000, изготавливаемых при воздействии температуры и давления [RU Пат. 2346696 А61К 33/00].A known method of stimulating the human immune system, including the introduction of therapeutic doses of mineral compounds osmoid iridium separately with mummy and propolis in ratios of 1: 1000, made under the influence of temperature and pressure [RU Pat. 2346696 A61K 33/00].
Недостатком данного способа является необоснованно высокая стоимость лечения и некоторый дискомфорт.The disadvantage of this method is the unreasonably high cost of treatment and some discomfort.
Цель изобретения - снижение стоимости лечения при улучшении комфорта.The purpose of the invention is to reduce the cost of treatment while improving comfort.
Поставленная задача достигается тем, что состав содержит порошкообразные следующие компоненты в массе %:The problem is achieved in that the composition contains the following powdered components in mass%:
При снижении уровня осмистого иридия с аконитом и вехом ядовитым менее 1% лечение затягивается на неопределенное время, а более 3% необоснованно повышается стоимость.With a decrease in the level of osmoid iridium with aconite and poisonous milestone less than 1%, the treatment is delayed indefinitely, and more than 3% the cost unreasonably increases.
При снижении уровня калия фосфорнокислого однозамещенного с чистотелом, натрия углекислого с зернами граната, этилендиамина со зверобоем каждого менее 20% - снижается метаболизм, а более 30% каждого необоснованно повышается стоимость.With a decrease in the level of potassium phosphate monosubstituted with celandine, sodium carbonate with pomegranate seeds, ethylenediamine with St. John's wort each less than 20%, the metabolism decreases, and more than 30% of each unreasonably increases the cost.
Пример конкретного применения см. табл. №1, 2, 3 изготовили состав, содержащий следующие компоненты в массе %:An example of a specific application, see table. No. 1, 2, 3 made a composition containing the following components in mass%:
Проведенный курс лечения 30 дней, при ежедневном 4-х разовом приеме через желудочно-кишечный тракт состава разовым приемом по 0,1 гр. за 30 минут до приема пищи показал следующие результаты (см. табл. №1, 2, 3).The course of treatment was 30 days, with a daily 4 single dose through the gastrointestinal tract of a single dose of 0.1 g. 30 minutes before a meal showed the following results (see table. No. 1, 2, 3).
Результаты проведенных исследований подтвердили стимулирование иммунной системы (см. табл. №3) и активации обменных процессов (см. табл. №1, 2).The results of the studies confirmed the stimulation of the immune system (see table. No. 3) and the activation of metabolic processes (see table. No. 1, 2).
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2018139177A RU2711629C1 (en) | 2018-11-06 | 2018-11-06 | Method for treating influenza and quinsy strains and composition for its implementation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2018139177A RU2711629C1 (en) | 2018-11-06 | 2018-11-06 | Method for treating influenza and quinsy strains and composition for its implementation |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2711629C1 true RU2711629C1 (en) | 2020-01-17 |
Family
ID=69171392
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2018139177A RU2711629C1 (en) | 2018-11-06 | 2018-11-06 | Method for treating influenza and quinsy strains and composition for its implementation |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2711629C1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2006228C1 (en) * | 1992-03-26 | 1994-01-30 | Александр Михайлович Шепеленко | Compound for treating influenza |
RU2245157C2 (en) * | 2001-08-09 | 2005-01-27 | Общество с ограниченной ответственностью "ЛЕОВИТ нутрио" (ООО "ЛЕОВИТ нутрио") | Biologically active additive for preventing and treating flu cases |
RU2346696C2 (en) * | 2006-06-29 | 2009-02-20 | Геннадий Михайлович Яковлев | Method of human immune system stimulation using activated platinoids-containing mineral, method of mineral activation and composition with immune system stimulation properties |
RU2396734C1 (en) * | 2009-04-30 | 2010-08-10 | Наталья Геннадьевна Яковлева | Resistance thin-film heater composition to use electromagnetic radiation for activating metabolism and stimulating human immune system |
-
2018
- 2018-11-06 RU RU2018139177A patent/RU2711629C1/en not_active IP Right Cessation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2006228C1 (en) * | 1992-03-26 | 1994-01-30 | Александр Михайлович Шепеленко | Compound for treating influenza |
RU2245157C2 (en) * | 2001-08-09 | 2005-01-27 | Общество с ограниченной ответственностью "ЛЕОВИТ нутрио" (ООО "ЛЕОВИТ нутрио") | Biologically active additive for preventing and treating flu cases |
RU2346696C2 (en) * | 2006-06-29 | 2009-02-20 | Геннадий Михайлович Яковлев | Method of human immune system stimulation using activated platinoids-containing mineral, method of mineral activation and composition with immune system stimulation properties |
RU2396734C1 (en) * | 2009-04-30 | 2010-08-10 | Наталья Геннадьевна Яковлева | Resistance thin-film heater composition to use electromagnetic radiation for activating metabolism and stimulating human immune system |
Non-Patent Citations (5)
Title |
---|
Ali Farid M.Ali et al. Bee propolis as a new modality for treatment of H1N1 Influenza. // Journal of American Science.- 2013; 9(12). * |
Ali Farid M.Ali et al. Bee propolis as a new modality for treatment of H1N1 Influenza. // Journal of American Science.- 2013; 9(12). Tomomi Shimizu et al. Anti-influenza virus activity of propolis in vitro and its efficacy against influenza infection in mice // Antiviral Chemistry & Chemotherapy.-2008.- 19:7-13. Лекарственные растения: фундаментальные и прикладные проблемы: материалы I Международной научной конференции (21-22 мая 2013 г., г. Новосибирск) / Новосиб. гос. аграр. ун-т. -Новосибирск: Изд-во НГАУ, 2013.- 537 с. Используем лечебные свойства травы аконит для своего здоровья. 17.10.2018. - [дата обращения: 02.07.2019], [интернет ресурс] https://glav-dacha.ru/lechebnye-svoystva-travy-akonit/. Штаммы и эпидемии гриппа. 23.01.2014. [дата обращения: 02.07.2019], [интернет ресурс] https://visual-science.com/ru/projects/influenza/illustration/. * |
Tomomi Shimizu et al. Anti-influenza virus activity of propolis in vitro and its efficacy against influenza infection in mice // Antiviral Chemistry & Chemotherapy.-2008.- 19:7-13. * |
Используем лечебные свойства травы аконит для своего здоровья. 17.10.2018. - [дата обращения: 02.07.2019], [интернет ресурс] https://glav-dacha.ru/lechebnye-svoystva-travy-akonit/. Штаммы и эпидемии гриппа. 23.01.2014. [дата обращения: 02.07.2019], [интернет ресурс] https://visual-science.com/ru/projects/influenza/illustration/. * |
Лекарственные растения: фундаментальные и прикладные проблемы: материалы I Международной научной конференции (21-22 мая 2013 г., г. Новосибирск) / Новосиб. гос. аграр. ун-т. -Новосибирск: Изд-во НГАУ, 2013.- 537 с * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2434640C2 (en) | Treatment of metastatic breast cancer | |
RU2356547C2 (en) | Cancer therapy with using hdac inhibitors | |
EA201650134A1 (en) | SPECIFIC COMBINED THERAPY OF MALIGNANT TUMORS BY CYTOSTATIC AND ITS MODIFIER | |
MX2022007371A (en) | Hypoparathyroidism treatment. | |
RU2568582C1 (en) | Method for non-specific immunoprophylaxis of bovine respiratory diseases | |
PH12019500242A1 (en) | 9-aminomethyl minocycline compounds and uses thereof | |
RU2711629C1 (en) | Method for treating influenza and quinsy strains and composition for its implementation | |
SG10201908089VA (en) | Novel dosing regimens of celgosivir for the treatment of dengue | |
Aminin et al. | Radioprotective properties of cumaside, a complex of triterpene glycosides from the sea cucumber Cucumaria japonica and cholesterol | |
MX2021012543A (en) | Chiral indole compounds and their use. | |
RU2711630C1 (en) | Method of treating tuberculosis and composition for its implementation | |
CN105147770A (en) | Composition having body odor removal function and preparation method and application thereof | |
RU2702124C2 (en) | Method for prevention and therapy of otoacariasis of carnivores and rabbit psoroptic mange | |
RU2346696C2 (en) | Method of human immune system stimulation using activated platinoids-containing mineral, method of mineral activation and composition with immune system stimulation properties | |
CN102731630A (en) | Antioxidant oligopeptide with skin penetration capability | |
RU2713167C1 (en) | Method of treating hepatitis and composition for implementation thereof | |
RU2702123C2 (en) | Method for prevention and therapy of otoacariasis of carnivores and rabbit psoroptic mange | |
RU2589694C1 (en) | Method for preventing and treating chronic fatigue syndrome | |
MX2021008658A (en) | Solid forms of ttk inhibitor. | |
RU2423990C1 (en) | Method of treating mastitis in cows | |
RU2612011C1 (en) | Enterosorbent | |
RU2418581C1 (en) | Application of musk deer musk tincture and ultraviolet irradiation of blood for treatment of spermatogenic failure in men of reproductive age | |
RU2161486C2 (en) | Method of treatment of patients with radiation-thermal damage and agent for its realization | |
EA004603B1 (en) | Method for preventing and treating diseases of an immune system and a remedy for carrying out said method | |
RU2339386C1 (en) | Agent possessing selective radio- and chemoprotective action |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20201107 |